Institutional members access full text with Ovid®

Share this article on:

CE: Genomic Breakthroughs in the Diagnosis and Treatment of Cystic Fibrosis

Nakano, Stephanie J. BSN, RN; Tluczek, Audrey PhD, RN

AJN The American Journal of Nursing: June 2014 - Volume 114 - Issue 6 - p 36–43
doi: 10.1097/01.NAJ.0000450425.66889.7e
Feature Articles

OVERVIEW Cystic fibrosis (CF) is an autosomal recessive disorder that was long considered a terminal illness. Recent genetic discoveries and genomic innovations, however, have transformed the diagnosis, classification, and treatment of this multisystem condition. For affected patients, these breakthroughs offer hope for significantly greater longevity and quality of life and, perhaps, for a future cure. This article reviews empirical research on CF, filling a critical gap in the nursing literature regarding recent findings in the study of CF genetics and their implications for patient teaching, diagnosis, and treatment.

This article describes recent genetic discoveries in the area of cystic fibrosis, the impact of new genomic advances on diagnosis and treatment, and implications for nursing practice, education, and research.

Stephanie J. Nakano is a staff nurse in the Department of Nursing and Patient Services and works in the pediatric ICU of American Family Children's Hospital, Madison, WI. Audrey Tluczek is an associate professor at the University of Wisconsin–Madison School of Nursing. Contact author: Audrey Tluczek, atluczek@wisc.edu. The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.

© 2014 Lippincott Williams & Wilkins. All rights reserved.